Mechanical distraction
A regulated vacuum gently draws tissue outward. The first response includes temporary stretch and fluid change.
The science behind EVEBRA
EVEBRA is designed around external tissue expansion: a sustained, low-level vacuum that gently draws breast tissue outward over many hours. The approach grew from Dr. Roger Khouri’s research with an earlier system, BRAVA.
About 12 hours of daily wear · 4–6 month recommended protocol · Individual results vary
01 / The underlying principle
When a gentle mechanical force is maintained, cells sense that force and the surrounding tissue can adapt. This response is called mechanotransduction. Tissue expansion has been studied across medical fields, including skin expansion and bone distraction.
EVEBRA applies a controlled vacuum through wearable domes. Its goal is gradual breast enlargement using the body’s own tissue response, without surgery or implants. Short bursts of suction can create temporary swelling; sustained wear is the key distinction in the external expansion research.
The biological pathway
The original page’s two medical illustrations and eight scientific notes are kept here, with plain-language context.

A regulated vacuum gently draws tissue outward. The first response includes temporary stretch and fluid change.
Cells detect the sustained force and respond through signaling pathways. This is the central biological principle behind tissue expansion.
Fibroblasts help make collagen and the extracellular matrix that supports tissue structure during adaptation.
Angiogenesis helps provide oxygen and nutrients as tissue changes. The response is gradual and varies by person.
With consistent tension, cells and their surrounding matrix can adapt. A single short wear session is different from a months-long protocol.

Biological and clinical outcomes
At the cellular level, mechanical expansion has been studied for its effects on cell activity, matrix remodeling and blood vessel formation. At the tissue level, temporary swelling can recede after wear stops.
In Khouri et al. (2000), 17 women enrolled and 12 completed an earlier external expansion protocol. MRI showed proportional enlargement of adipose and fibroglandular tissue without edema at the measured follow-up. Some early volume receded after stopping; the study reported no significant further reduction during follow-up of up to 30 weeks. It was a small study without a control group, and individual outcomes varied.
02 / What to expect
These original EVEBRA illustrations explain the proposed process. Week labels are illustrative, not a timetable or promise of a particular result.

The original inset depicts glandular tissue and fat lobules before the wear protocol begins.

Vacuum gently draws the tissue outward. Early visible fullness can include temporary swelling.

Sustained daily tension is intended to support gradual tissue expansion. Timing and degree of change vary.

Temporary fullness may recede. Earlier-system research used MRI to assess tissue change after this settling period. Retention varies.
03 / The daily commitment
EVEBRA’s recommended protocol is about 12 hours of daily wear for 4–6 months. Many people wear it overnight.

The “Cinderella effect”
Short-term vacuum can create visible fullness from a temporary fluid response. The original page calls this the “Cinderella effect.” That appearance can settle after the device is removed.
Published research on the earlier external expansion method studied prolonged, repeated wear and used MRI to distinguish measured tissue change from fluid alone. A consistent pattern matters more than judging a single day’s appearance.
See if the routine fits your life
Wear-time illustrations
The four charts from the current page are retained as conceptual examples. Their percentages and curves should not be read as validated thresholds or personal forecasts.




04 / Read the evidence
These publications concern BRAVA or earlier external expansion systems. Read the findings, study designs and limitations before applying them to EVEBRA.

Khouri RK, Schlenz I, Murphy BJ, Baker TJ. Plastic and Reconstructive Surgery. 105(7):2500–2512. Seventeen enrolled; twelve completed the single-group protocol.
Read the paper
Schlenz I, Kaider A. Plastic and Reconstructive Surgery. 120(6):1680–1689. Fifty women began; forty were evaluated after treatment. Wear intensity was associated with outcomes.
Read the paper
Khouri RK et al. Presented at the American Society of Plastic Surgeons. A conference abstract is a different level of detail from a full peer-reviewed paper.
See all publicationsThe studies above investigated earlier devices and protocols. They do not guarantee an EVEBRA result. Individual results depend on fit, consistent use and personal biology.
Hear it from the inventor
Watch the original whiteboard explanation from Dr. Roger Khouri, inventor of BRAVA and EVEBRA.
Meet Dr. KhouriReady to look closer?
Review candidacy, fit and the current product details before ordering.
$1,799 $2,499
Save $700 with code FALL700 and get a free pump carrying bag with your device. Ends October 31 at 11:59 pm ET.
View EVEBRA with FALL700